Allegria Therapeutics
Basel
About Allegria Therapeutics
Allegria Therapeutics is a biotech research company that specializes in the diagnosis and treatment of allergy and allergy and inflammatory diseases associated with mast cell dysfunction.
Company Facts
- Operating status: Active
- Company type: For Profit
- IPO status: Private
- Employees: 1 – 10
- Estimated revenue: $1K – $10K
- Total funding: $8.6M
- Funding stage: Seed
- Last round: Seed (Dec 2025)
- Website: allegriatx.com
- Phone: [email protected]
Industries & Categories
Biotechnology, Health Diagnostics, Life Science, Therapeutics
Social Profiles
Canonical: https://fsome.com/organization/allegria-therapeutics-20804 · For the full interactive profile (charts, investors, team, acquisitions, press), please enable JavaScript.